BRIEF-Fennec Says Phase 3 SIOPEL 6 Study Met Primary Endpoint By: Reuters: Company News March 26, 2018 at 06:37 AM EDT * FENNEC PROVIDES BUSINESS UPDATE AND ANNOUNCES FISCAL YEAR ENDED DECEMBER 31, 2017 FINANCIAL RESULTS Read More >> Related Stocks: Fennec Pharmaceuticals Inc